<DOC>
	<DOCNO>NCT01829685</DOCNO>
	<brief_summary>The purpose study compare long-term efficacy safety entecavir 1.0 mg/d + adefovir 10 mg/d entecavir 0.5 mg/d + adefovir 10 mg/d chronic hepatitis B patient inadequate response NUC therapy</brief_summary>
	<brief_title>Efficacy Optimizing Extension Study Chronic Hepatitis B Patients With Inadequate Response NUC Therapy</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Hepatitis B , Chronic</mesh_term>
	<mesh_term>Adefovir</mesh_term>
	<mesh_term>Adefovir dipivoxil</mesh_term>
	<mesh_term>Entecavir</mesh_term>
	<criteria>Subjects complete 104week Dragon study . Subjects willing participate extension study . Subjects could compliance protocol judge investigator</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2014</verification_date>
</DOC>